Revenue of $729 million; pro forma revenue of $710 million; 7% pro forma revenue growth; 7% pro forma organic revenue growth
GAAP EPS from continuing operations of $0.56; adjusted EPS from continuing operations of
The Board of Directors of Revvity, Inc. (NYSE:RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on February 12, 2027 to all shareholders of record at the
AI-first solution bridges workflow coordination gaps and accelerates technology transfer from early discovery through development and manufacturing
Multi-tier execution, centralized data and real-time monitoring
Revvity, Inc. (NYSE:RVTY), today announced it will present at the following investor conferences:
2026 Jefferies Global Healthcare Conference
Tuesday, November 17, 2026
8:00 a.m. GMT – Prahlad Singh, president and
Revvity, Inc. (NYSE:RVTY), today announced it will host its 2026 Investor Day on Friday, November 13 at 9:00 a.m. ET.Presentations from members of Revvity’s senior management team will provide updates on the Company’s
Revvity, Inc. (NYSE:RVTY), today announced that it will release its third quarter 2026 financial results prior to market open on Tuesday, November 3, 2026. The Company will host a conference call the same day at 7:30
Acquisition strengthens Revvity’s position in human-relevant life sciences tools for next-generation GLP-1 and GPCR-targeting therapies for metabolic drug discovery
Combines HCD’s human pancreatic beta cell models
Revenue of $730 million; pro forma revenue of $711 million; 4% pro forma revenue growth; 3% pro forma organic revenue growth
GAAP EPS from continuing operations of $0.48; adjusted EPS from continuing operations of
The Board of Directors of Revvity, Inc. (NYSE:RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on November 13, 2026 to all shareholders of record at the
Revvity, Inc. (NYSE:RVTY) today published its 2026 Impact Report, highlighting the Company’s sustainability, social and governance strategy, initiatives and performance. The annual report showcases how the Company
Revvity, Inc. (NYSE:RVTY), today announced that it will release its second quarter 2026 financial results prior to market open on Tuesday, August 4, 2026. The Company will host a conference call the same day at 7:30
New MCP connector extends Signals AI beyond the Signals One platform, enabling scientists to interact with connected R&D knowledge through Claude
Claude accesses scientific data and organizational knowledge
Scientists can now search, understand and act on complex R&D data in natural language by leveraging leading LLM capabilities within the Signals One platform
Governed data and ontology-driven scientific context
Revenue of $711 million; pro forma revenue of $687 million; 7% revenue growth; 3% organic growth; 6% pro forma organic growth
GAAP EPS from continuing operations of $0.37; adjusted EPS from continuing operations of
